The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations

被引:8
|
作者
Tawil, Samah [1 ,2 ]
Irani, Carla [3 ]
Kfoury, Riwa [4 ]
Salameh, Pascale [4 ,5 ,6 ]
Baiardini, Ilaria [7 ]
Weller, Karsten [8 ]
Maurer, Marcus [8 ]
Ezzedine, Khaled [9 ,10 ]
机构
[1] Lebanese Order Pharmacists, Drug Informat Ctr, Beirut, Lebanon
[2] Lebanese Order Pharmacists, Continuing Educ Dept, Beirut, Lebanon
[3] St Joseph Univ, Hotel Dieu France Hosp, Internal Med & Clin Immunol, Beirut, Lebanon
[4] Lebanese Univ, Fac Med Sci, Hadath, Lebanon
[5] INSPECT LB Inst Natl Sante Publ Epidemiol Clin &, Beirut, Lebanon
[6] Lebanese Univ, Fac Pharm & Med Sci, Hadath, Lebanon
[7] Univ Genoa, RCCS AOU San Martino IST, DIMI, Allergy & Resp Dis Clin, Genoa, Italy
[8] Charite Univ Med Berlin, Dermatol Allergol, Dept Dermatol & Allergy, Allergie Ctr Charite, Berlin, Germany
[9] Henri Mondor Univ Hosp, Dept Dermatol, Creteil, France
[10] UPEC Univ, EA7379, Epiderm E Epidemiol Dermatol & Therapeut Evaluat, Creteil, France
关键词
DISEASE-ACTIVITY; IMPORTANT DIFFERENCE; CULTURAL-ADAPTATION; VERSION; INDEX; INSTRUMENT; EXPERIENCE; BURDEN;
D O I
10.1111/ijd.15006
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background The international guideline for urticaria recommends the use of the Urticaria Activity Score 7 (UAS7) and the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) to assess patients with chronic spontaneous urticaria (CSU) for their disease activity and impact on quality of life, respectively. Over the last decade, both tools have been validated in many different languages but not in Arabic. Objective To validate the Arabic UAS7 and CU-Q2oL in patients with CSU in Lebanon. Methods After a structured translation process of both instruments into Arabic, their construct and known-groups validity as well as internal consistency reliability were tested in a longitudinal prospective study using a cluster sample of 152 Lebanese CSU patients. The study also included a repetitive administration of both instruments in 2-week intervals in 44 patients in order to assess their test-retest reliability. Results Both the Arabic UAS7 and CU-Q2oL demonstrated high internal consistency (Cronbach alpha of 0.95 and 0.82, respectively) and moderate-to-high test-retest reliability (intraclass coefficient of 0.61 and 0.91, respectively). Exploratory factor analysis of the Arabic CU-Q2oL revealed five components that explained 81.8% of the total variance. Significant correlations were found between the Arabic CU-Q2oL and the Dermatology Life Quality Index (DLQI) (r = 0.86) and mild-to-moderate correlations between the Arabic UAS7 and CU-Q2oL (r = 0.52) as well as the DLQI (r = 0.51). Conclusions Our findings demonstrate that the Arabic versions of the UAS7 and the CU-Q2oL are valid and reliable patient-reported outcome measures in patients with CSU in Lebanon.
引用
收藏
页码:893 / 901
页数:9
相关论文
共 50 条
  • [21] Quality of life and disease activity assessment in patients with chronic urticaria
    Dias, G. A. C.
    Fernanda, C. C.
    Pennaforte, C.
    Caputo, F.
    Filippo, P.
    Arraes, A. C. N.
    Denise, P. L.
    Perello, M., I
    Costa, E.
    ALLERGY, 2015, 70 : 643 - 643
  • [22] Validation of chronic spontaneous/idiopathic urticaria (CSU/CIU) health states using weekly urticaria activity score (UAS7) and Dermatology Life Quality Index (DLQI)
    Stull, Donald
    McBride, Doreen
    Gimenez-Arnau, Ana
    Grattan, Clive
    Khalil, Sam
    Balp, Maria-Magdalena
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB154 - AB154
  • [23] Development and validation of an urticaria questionnaire
    McGrath, C
    Johnson, KI
    Abetz, L
    QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 241 - 241
  • [24] Adaptation and Validation of the Spanish Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)
    Valero, A.
    Herdman, M.
    Bartra, J.
    Ferrer, M.
    Jauregui, I.
    Davilla, I.
    del Cuvillo, A.
    Montoro, J.
    Mullol, J.
    Sastre, J.
    Canonica, G. W.
    Baiardini, I.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2008, 18 (06) : 426 - 432
  • [25] The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings
    Mlynek, A.
    Magerl, M.
    Hanna, M.
    Lhachimi, S. K.
    Baiardini, I.
    Canonica, G. W.
    Brzoza, Z.
    Kasperska-Zajac, A.
    Rogala, B.
    Zalewska-Janowska, A.
    Zuberbier, T.
    Maurer, M.
    ALLERGY, 2009, 64 (06) : 927 - 936
  • [26] Initial data of the cross-cultural adaptation/validation of the Greek version of chronic urticaria quality of life questionnaire
    Koti, I
    Makris, M.
    Weller, K.
    Tyligada, K.
    Papageorgiou, C.
    Maurer, M.
    ALLERGY, 2012, 67 : 497 - 497
  • [27] Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)
    Kessel, Aharon
    Graif, Yael
    Vadasz, Zahava
    Schichter-Konfino, Vered
    Almog, Meital
    Cohen, Shai
    Teplitski, Valery
    Stein, Nili
    Baiardini, Ilaria
    Maurer, Marcus
    Toubi, Elias
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (08): : 461 - 465
  • [28] Validation of the Chronic Urticaria Quality of Life questionnaire (CU-Q2oL) in a Spanish patient population
    Valero, A.
    Herdman, M.
    Ferrer, M.
    Jauregui, I
    Bartra, J.
    Davila, I
    del Cuvillo, A.
    Montoro, J.
    Mulllol, J.
    Sastre, J.
    ALLERGY, 2008, 63 : 156 - 156
  • [29] Adaptation and validation of the Bengali version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)
    Dhabal, Arunima
    Mondal, Himel
    Mondal, Shaikat
    Baiardini, Ilaria
    Chakraborty, Sankha Subhra
    Chakraborty, Tamali
    Podder, Indrashis
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2023, 89 (03): : 385 - 392
  • [30] Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL)
    Ruft, J.
    Asady, A.
    Staubach, P.
    Casale, T.
    Sussmann, G.
    Zuberbier, T.
    Maurer, M.
    Weller, K.
    Altrichter, S.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (04): : 433 - 444